NCT01268709

Brief Summary

The objective of this randomized triple blind controlled trial is to compare the effects of Doxepin and Nortriptyline on diarrhea predominant irritable bowel syndrome. In this stuy, 75 patients with IBS are randomly assigned to receive Doxepin , Nortriptyline or placebo, a tablet per day, orally, for two months. Abdominal pain, mucus in the stool, incomplete evacuation, and bloating are measured and compared between groups at the baseline and one and two month after the intervention.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 31, 2010

Completed
Last Updated

December 31, 2010

Status Verified

December 1, 2010

First QC Date

December 30, 2010

Last Update Submit

December 30, 2010

Conditions

Study Arms (3)

doxepin

ACTIVE COMPARATOR
Drug: Doxepin

nortriptyline

ACTIVE COMPARATOR
Drug: Nortriptyline

placebo

PLACEBO COMPARATOR
Drug: placebo

Interventions

doxepin
nortriptyline
placebo

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of diarrhea predominant irritable bowel syndrome according to ROME criteria

You may not qualify if:

  • Gastrointestinal bleeding
  • More than 5% weight loss in the last 6 months
  • Presence of any finding in favor of organic disorders in the lab tests or organic disorder in colonoscopy of high risk patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gastrointestinal Research center,Beheshti Hospital

Qom, Qom Province, 1677859642, Iran

Location

MeSH Terms

Conditions

Irritable Bowel Syndrome

Interventions

DoxepinNortriptyline

Condition Hierarchy (Ancestors)

Colonic Diseases, FunctionalColonic DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

OxepinsEthers, CyclicEthersOrganic ChemicalsDibenzoxepinsHeterocyclic Compounds, 3-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsDibenzocycloheptenesBenzocycloheptenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsPolycyclic Compounds

Study Design

Study Type
interventional
Phase
phase 2
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 30, 2010

First Posted

December 31, 2010

Last Updated

December 31, 2010

Record last verified: 2010-12

Locations